Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 19269085 | HYDROTHERAPY MACHINE | July 2025 | October 2025 | Allow | 3 | 0 | 0 | No | No |
| 18073587 | AUTOMATIC MASSAGE PORTABLE MASSAGE TABLE | December 2022 | August 2025 | Abandon | 33 | 1 | 0 | No | No |
| 17927121 | RESPIRATOR MASK | November 2022 | February 2026 | Abandon | 39 | 1 | 0 | No | No |
| 17989487 | SUPPORT FOOT FOR AN EXOSKELETON FOR CARRYING LOADS, EXOSKELETON COMPRISING SAID SUPPORT FOOT AND METHOD OF CONTROLLING AN EXOSKELETON | November 2022 | February 2026 | Abandon | 39 | 1 | 0 | No | No |
| 17972543 | ELECTRIC STRETCHING DEVICE | October 2022 | January 2026 | Abandon | 39 | 1 | 0 | No | No |
| 17916846 | RESPIRATORY AIR DISINFECTION DEVICE, RESPIRATORY PROTECTION MASK WITH SAME AND RESPIRATORY AIR DISINFECTION METHOD WITH SAME | October 2022 | January 2026 | Abandon | 40 | 1 | 0 | No | No |
| 17907519 | FACE MASK APPARATUS WITH SECONDARY FILTER | September 2022 | January 2026 | Abandon | 39 | 1 | 0 | No | No |
| 17889247 | APPARATUS FOR ASSISTING MUSCULAR STRENGTH | August 2022 | February 2026 | Allow | 42 | 1 | 0 | No | No |
| 17864355 | CLUTCH ADAPTED FOR EXOSKELETON AND ANKLE JOINT ASSISTED EXOSKELETON | July 2022 | September 2025 | Allow | 38 | 0 | 0 | No | No |
| 17791530 | Stationary automated device for lower limb rehabilitation | July 2022 | March 2026 | Abandon | 44 | 1 | 0 | No | No |
| 17757754 | BALANCE DEVICE WITH PIVOTABLE PLATE | June 2022 | December 2025 | Abandon | 42 | 1 | 0 | No | No |
| 17824466 | CPR CHEST COMPRESSION MACHINE | May 2022 | November 2025 | Abandon | 42 | 1 | 0 | No | No |
| 17737811 | GENERATING SETTINGS FOR VENTILATORS USING MACHINE LEARNING TECHNIQUES | May 2022 | December 2025 | Abandon | 44 | 1 | 0 | No | No |
| 17721437 | FACIAL PROTECTION ELEMENT FOR PROTECTION AGAINST RISKS OF EXPOSURE TO INFECTIOUS BIOLOGICAL AGENTS | April 2022 | October 2025 | Abandon | 43 | 1 | 0 | No | No |
| 17659000 | WALKING TRAINING SYSTEM, CONTROL METHOD THEREOF, AND CONTROL PROGRAM | April 2022 | September 2025 | Allow | 41 | 1 | 0 | No | No |
| 17701850 | COMPRESSION DEVICE AND METHOD OF USE | March 2022 | October 2025 | Abandon | 43 | 1 | 0 | No | No |
| 17697394 | FASCIAL GUN HAVING FUNCTION OF INTELLIGENTLY ADJUSTING STRIKING | March 2022 | October 2025 | Allow | 43 | 1 | 1 | No | No |
| 17655087 | BREATHING CONTROL DEVICE | March 2022 | September 2025 | Abandon | 42 | 1 | 0 | No | No |
| 17753543 | METHODS AND SYSTEMS FOR CONTROLLING OXYGEN DELIVERY IN A FLOW THERAPY APPARATUS | March 2022 | January 2025 | Allow | 35 | 0 | 0 | No | No |
| 17639072 | NASAL SPRAY MEDICAMENT TRAINING DEVICE | February 2022 | October 2025 | Allow | 43 | 1 | 0 | Yes | No |
| 17583708 | MASK APPARATUS | January 2022 | July 2025 | Allow | 41 | 1 | 0 | No | No |
| 17579234 | TELEKINETIC BIONIC GLOVE ASSEMBLY | January 2022 | April 2025 | Allow | 38 | 1 | 0 | No | No |
| 17519231 | Ear Mounted Cannular Nasal Breathing Filter | November 2021 | February 2025 | Allow | 39 | 1 | 0 | Yes | No |
| 17453267 | FACE PROTECTION MASK | November 2021 | September 2025 | Abandon | 46 | 2 | 0 | No | No |
| 17511690 | Vibrating Garment to Reduce Muscle Pain During Intense Exercise | October 2021 | March 2025 | Abandon | 41 | 1 | 0 | No | No |
| 17509420 | Rechargeable Hoseless CPAP System | October 2021 | April 2025 | Abandon | 42 | 1 | 0 | No | No |
| 17508765 | CPR DEVICE WITH PIVOTING SUPPORT ARM | October 2021 | October 2025 | Allow | 47 | 3 | 0 | Yes | No |
| 17498223 | Disposable Masks with Improved Life Span | October 2021 | February 2025 | Abandon | 40 | 0 | 1 | No | No |
No appeal data available for this record. This may indicate that no appeals have been filed or decided for applications in this dataset.
Examiner RHEE, KELSEY works in Art Unit 3785 and has examined 6 patent applications in our dataset. With an allowance rate of 33.3%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 42 months.
Examiner RHEE, KELSEY's allowance rate of 33.3% places them in the 5% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.
On average, applications examined by RHEE, KELSEY receive 1.33 office actions before reaching final disposition. This places the examiner in the 19% percentile for office actions issued. This examiner issues significantly fewer office actions than most examiners.
The median time to disposition (half-life) for applications examined by RHEE, KELSEY is 42 months. This places the examiner in the 20% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.
Conducting an examiner interview provides a +100.0% benefit to allowance rate for applications examined by RHEE, KELSEY. This interview benefit is in the 100% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.
When applicants file an RCE with this examiner, 50.0% of applications are subsequently allowed. This success rate is in the 98% percentile among all examiners. Strategic Insight: RCEs are highly effective with this examiner compared to others. If you receive a final rejection, filing an RCE with substantive amendments or arguments has a strong likelihood of success.
This examiner enters after-final amendments leading to allowance in 0.0% of cases where such amendments are filed. This entry rate is in the 4% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.
Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 47% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 49% percentile). This examiner issues Quayle actions less often than average. Allowances may come directly without a separate action for formal matters.
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.